Inhibitory effects of curcumin on gastric cancer cells: A proteomic study of molecular targets

Phytomedicine

Volumn 20, Issue 6, 2013, Pages 495-505

  Cai, X Z ^a   Huang, W Y ^a   Qiao, Y ^a   Du, S Y ^a   Chen, Y ^a   Chen, D ^a   Yu, S ^a   Che, R C ^a   Liu, N ^a   Jiang, Y ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Curcumin; Gastric cancer; Mass spectrometry; Molecular targets; Proteomics

Indexed keywords

CURCUMIN; LIPOCORTIN 5; PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DENSITOMETRY; DOWN REGULATION; DRUG MECHANISM; ELECTRIC POTENTIAL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; ISOELECTRIC FOCUSING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLISM; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOMICS; SIGNAL TRANSDUCTION; STOMACH CANCER; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMA; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEOPLASM PROTEINS; PHYTOTHERAPY; PLANT EXTRACTS; PROTEOMICS; STOMACH NEOPLASMS;

ANIMALIA;

EID: 84875962976     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2012.12.007     Document Type: Article

References (52)

1. D.M. Adyshev, N.K. Moldobaeva, V.R. Elangovan, J.G. Garcia, and S.M. Dudek Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement Cellular Signalling 23 2011 2086 2096
2. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Molecular Pharmaceutics 4 2007 807 818
3. Y. Asaoka, T. Ikenoue, and K. Koike New targeted therapies for gastric cancer Expert Opinion on Investigational Drugs 20 2011 595 604
4. D. Brambilla, and S. Fais The Janus-faced role of ezrin in "linking" cells to either normal or metastatic phenotype International Journal of Cancer 125 2009 2239 2245
5. X.Z. Cai, J. Wang, X.D. Li, G.L. Wang, F.N. Liu, M.S. Cheng, and F. Li Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression Cancer Biology and Therapy 8 2009 1360 1368
6. F. Cappello, E. Conway de Macario, L. Marasa, G. Zummo, and A.J. Macario Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy Cancer Biology and Therapy 7 2008 801 809
7. C. Chen, Y. Liu, Y. Chen, and J. Xu C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFkappaB in colon cancer cells and xenograft tumors Cancer Biology and Therapy 12 2011 797 807
8. D.R. Ciocca, and S.K. Calderwood Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications Cell Stress and Chaperones 10 2005 86 103
9. D.R. Ciocca, N. Cayado-Gutierrez, M. Maccioni, and F.D. Cuello-Carrion Heat Shock Proteins (HSPs) based anti-cancer vaccines Current Molecular Medicine 2012 (Epub ahead of print)
10. C. Coghlin, B. Carpenter, S.R. Dundas, L.C. Lawrie, C. Telfer, and G.I. Murray Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer Journal of Pathology 210 2006 351 357
11. E.M. Creagh, D. Sheehan, and T.G. Cotter Heat shock proteins - modulators of apoptosis in tumour cells Leukemia 14 2000 1161 1173
12. C.W. D'Acunto, B. Fontanella, M. Rodriquez, M. Taddei, L. Parente, and A. Petrella Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1 Cancer Letters 295 2010 85 91
13. M. Ernst, M. Najdovska, D. Grail, T. Lundgren-May, M. Buchert, H. Tye, V.B. Matthews, J. Armes, P.S. Bhathal, N.R. Hughes, E.G. Marcusson, J.G. Karras, S. Na, J.D. Sedgwick, P.J. Hertzog, and B.J. Jenkins STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice Journal of Clinical Investigation 118 2008 1727 1738
14. H.Y. Fang, S.B. Chen, D.J. Guo, S.Y. Pan, and Z.L. Yu Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells Phytomedicine 18 2011 697 703
15. P.C. Faria, A.A. Sena, R. Nascimento, W.J. Carvalho, A.M. Loyola, S.J. Silva, A.F. Durighetto, A.D. Oliveira, S.M. Oliani, and L.R. Goulart Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients Oral Oncology 46 2010 25 30
16. M.J. Fullwood, W. Zhou, and S. Shenolikar Targeting phosphorylation of eukaryotic initiation factor-2alpha to treat human disease Progress in Molecular Biology and Translational Science 106 2012 75 106
17. Y. Gachet, S. Tournier, M. Lee, A. Lazaris-Karatzas, T. Poulton, and U.A. Bommer The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle Journal of Cell Science 112 1999 1257 1271
18. B. Gibert, B. Eckel, V. Gonin, D. Goldschneider, J. Fombonne, B. Deux, P. Mehlen, A.P. Arrigo, P. Clezardin, and C. Diaz-Latoud Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo British Journal of Cancer 107 2012 63 70
19. M. Gnanasekar, S. Thirugnanam, G. Zheng, A. Chen, and K. Ramaswamy Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells International Journal of Oncology 34 2009 1241 1246
20. Y. He, A.M. Correa, M.G. Raso, W.L. Hofstetter, B. Fang, C. Behrens, J.A. Roth, Y. Zhou, L. Yu, I.I. Wistuba, S.G. Swisher, and A. Pataer The role of PKR/eIF2alpha signaling pathway in prognosis of non-small cell lung cancer PLoS ONE 6 2011 e24855
21. S. Huang, M. Chen, Y. Shen, W. Shen, H. Guo, Q. Gao, and X. Zou Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells Cancer Letters 315 2011 198 205
22. L.J. Jensen, M. Kuhn, M. Stark, S. Chaffron, C. Creevey, J. Muller, T. Doerks, P. Julien, A. Roth, M. Simonovic, P. Bork, and C. von Mering STRING 8 - a global view on proteins and their functional interactions in 630 organisms Nucleic Acids Research 37 2009 D412 D416
23. C. Khanna, X. Wan, S. Bose, R. Cassaday, O. Olomu, A. Mendoza, C. Yeung, R. Gorlick, S.M. Hewitt, and L.J. Helman The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nature Medicine 10 2004 182 186
24. R. Kumar, A.E. Gururaj, and C.J. Barnes p21-Activated kinases in cancer Nature Reviews Cancer 6 2006 459 471
25. A.B. Kunnumakkara, P. Anand, and B.B. Aggarwal Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins Cancer Letters 269 2008 199 225
26. J.Y. Lee, Y.M. Lee, G.C. Chang, S.L. Yu, W.Y. Hsieh, J.J. Chen, H.W. Chen, and P.C. Yang Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy PLoS ONE 6 2011 e23756
27. F. Li, D. Zhang, and K. Fujise Characterization of fortilin, a novel antiapoptotic protein Journal of Biological Chemistry 276 2001 47542 47549
28. S.J. Li, H.Y. Jia, D. Wu, and Z.M. Fan Expression of translationally controlled tumor protein in human breast cancer and its clinical significance Nan Fang Yi Ke Da Xue Xue Bao 31 2011 1560 1563
29. Y.R. Li, E. Akbari, M.S. Tretiakova, J. Hart, M. Akbari, S.J. Urbanski, and Z.H. Gao Primary hepatic malignant fibrous histiocytoma: clinicopathologic characteristics and prognostic value of ezrin expression American Journal of Surgical Pathology 32 2008 1144 1158
30. L. Lin, B. Hutzen, S. Ball, E. Foust, M. Sobo, S. Deangelis, B. Pandit, L. Friedman, C. Li, P.K. Li, J. Fuchs, and J. Lin New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells Cancer Science 100 2009 1719 1727
31. L. Lindqvist, and J. Pelletier Inhibitors of translation initiation as cancer therapeutics Future Medicinal Chemistry 1 2009 1709 1722
32. H. Liu, H.W. Peng, Y.S. Cheng, H.S. Yuan, and H.F. Yang-Yen Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP Molecular and Cellular Biology 25 2005 3117 3126
33. W.Y. Lo, H.J. Wang, C.W. Chiu, and S.F. Chen miR-27b-regulated TCTP as a novel plasma biomarker for oral cancer: from quantitative proteomics to post-transcriptional study Journal of Proteomics 2012 (Epub ahead of print)
34. N. Magan, R.J. Isaacs, and K.M. Stowell Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells Anti-Cancer Drugs 23 2012 627 637
35. J. Nawarak, R. Huang-Liu, S.H. Kao, H.H. Liao, S. Sinchaikul, S.T. Chen, and S.L. Cheng Proteomics analysis of kojic acid treated A375 human malignant melanoma cells Journal of Proteome Research 7 2008 3737 3746
36. B.B. Patel, and A.P. Majumdar Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview Nutrition and Cancer 61 2009 842 846
37. F. Robert, and J. Pelletier Translation initiation: a critical signalling node in cancer Expert Opinion on Therapeutic Targets 13 2009 1279 1293
38. W.S. Siegel-Lakhai, J.H. Beijnen, and J.H. Schellens Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa) Oncologist 10 2005 579 589
39. J. Slotta-Huspenina, D. Berg, K. Bauer, C. Wolff, K. Malinowsky, L. Bauer, E. Drecoll, M. Bettstetter, M. Feith, A. Walch, H. Hofler, K.F. Becker, and R. Langer Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas PLoS ONE 7 2012 e41420
40. L. Susini, S. Besse, D. Duflaut, A. Lespagnol, C. Beekman, G. Fiucci, A.R. Atkinson, D. Busso, P. Poussin, J.C. Marine, J.C. Martinou, J. Cavarelli, D. Moras, R. Amson, and A. Telerman TCTP protects from apoptotic cell death by antagonizing bax function Cell Death and Differentiation 15 2008 1211 1220
41. Y. Tabe, L. Jin, R. Contractor, D. Gold, P. Ruvolo, S. Radke, Y. Xu, Y. Tsutusmi-Ishii, N. Miyake, I. Kagaoka, M. Andreeff, and M. Konopleva Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1 Cell Death and Differentiation 14 2007 1443 1456
42. T. Tsumuraya, C. Ishikawa, Y. Machijima, S. Nakachi, M. Senba, J. Tanaka, and N. Mori Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia Biochemical Pharmacology 81 2011 713 722
43. A.D. Wagner, and U. Wedding Advances in the pharmacological treatment of gastro-oesophageal cancer Drugs and Aging 26 2009 627 646
44. D. Wang, H. Zhang, Z. Fang, and G. Yu Annexin-1 downregulation is associated with clinical outcome in Chinese patients with hilar cholangiocarcinoma European Surgical Research 45 2010 151 157
45. J.W. Wang, S.Y. Peng, J.T. Li, Y. Wang, Z.P. Zhang, Y. Cheng, D.Q. Cheng, W.H. Weng, X.Z. Wu, X.Z. Fei, Z.W. Quan, J.Y. Li, S.G. Li, and Y.B. Liu Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1 Cancer Letters 281 2009 71 81
46. X. Wang, Y. Zhang, X. Zhang, W. Tian, W. Feng, and T. Chen The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition International Journal of Oncology 40 2011 1189 1195
47. R. Wilken, M.S. Veena, M.B. Wang, and E.S. Srivatsan Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma Molecular Cancer 10 2011 12
48. W.K. Wu, C.H. Cho, C.W. Lee, D. Fan, K. Wu, J. Yu, and J.J. Sung Dysregulation of cellular signaling in gastric cancer Cancer Letters 295 2010 144 153
49. N. Yamagata, K. Furuno, M. Sonoda, H. Sugimura, and K. Yamamoto Stomach cancer-derived del223V-226L mutation of the STCH gene causes loss of sensitization to TRAIL-mediated apoptosis Biochemical and Biophysical Research Communications 376 2008 499 503
50. C.K. Yom, W. Han, S.W. Kim, H.S. Kim, H.C. Shin, J.N. Chang, M. Koo, D.Y. Noh, and B.I. Moon Clinical significance of annexin A1 expression in breast cancer Journal of Breast Cancer 14 2011 262 268
51. G. Yu, J. Wang, Y. Chen, X. Wang, J. Pan, Q. Li, and K. Xie Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer Clinical and Experimental Metastasis 25 2008 695 702
52. D. Zhang, F. Li, D. Weidner, Z.H. Mnjoyan, and K. Fujise Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone Journal of Biological Chemistry 277 2002 37430 37438